Good News Tuesday: Entrada Therapeutics supports initiatives to help those with Duchenne Muscular Dystrophy

Entrada Therapeutics Inc. a biopharmaceutical company aiming to transform the lives of patients through its new class of medicines, has announced recipients of its inaugural Entrada DREAMS Grant Program.

Editor’s picks: Some of my favorite stories of 2018

What lured Japanese conglomerate to invest $233 million in Davidson County?

With Olathe Health deal, KU Health System faces competitive Southern Johnson County market

Amgen-partnered neuroscience startup rakes in another $112M

Mosaic District owner sues Mike Isabella for more than $700K

Chandler to land Wells Fargo jobs moving out of San Francisco

Biz: Cary’s Fenton adds a gem to lineup; Triangle leader among CNN Heroes

The number of $1M earners is surging. Here’s how many Oregon added

Good News Tuesday: Entrada Therapeutics supports initiatives to help those with Duchenne Muscular Dystrophy

Previous Beverly Hills-based buyer picks up Northside apartments for $7.5M

Next Virginia Tech receives record-tying $50M donation from Richmond's Red Gates Foundation

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Fidelity’s Abby Johnson strikes deal to stay off stand in MIT 401(k) trial

There’s little doubt the money will flow to Opportunity Zones. Then it’s anyone’s guess.

Bessemer rehabilitation center property sells for $9 million

DFW home sellers, buyers need to adjust expectations as housing market shifts

Litigation finance firm Westfleet Advisors opens Houston office, expands exec team with local hire

Mixed-use office, residential, retail complex eyed near Trader Joe’s

MENU

FirstStar Group

More Stories

Carl Icahn sues Dell over ‘forced IPO conversion’